Anticoagulant Citrate Dextrose A .22 g/10mL

Anticoagulant Citrate Dextrose A .22 g/10mL is a solution designed for use in extracorporeal circuits. It contains anhydrous citric acid, dextrose monohydrate, and trisodium citrate dihydrate. This product is manufactured by Citra Labs LLC in the USA.

Anticoagulant Citrate Dextrose A .22 g/10mL is primarily used to prevent blood clotting in extracorporeal circuits. It is often utilized in medical procedures that require blood to be circulated outside the body, such as dialysis or blood transfusion. The solution helps maintain the blood in a fluid state, ensuring smooth operation of the equipment. What is Anticoagulant Citrate Dextrose A used for? It is commonly used in settings where anticoagulation is necessary to prevent clotting during procedures.

Anticoagulant Citrate Dextrose A .22 g/10mL works by binding calcium ions in the blood, which are essential for the clotting process. This action helps to keep the blood in a fluid state, reducing the risk of clots forming in extracorporeal circuits. The solution is designed to be compatible with various medical devices and procedures that require blood to be circulated outside the body.

When handling Anticoagulant Citrate Dextrose A .22 g/10mL, it is important to follow proper safety protocols. The solution should be stored and used according to the manufacturer's instructions to ensure its effectiveness and safety. Always check the packaging for any specific handling instructions and ensure that the solution is used within its expiration date.

Anticoagulant Citrate Dextrose A .22 g/10mL may interact with other medications or substances that affect blood clotting. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Additionally, the solution should not be mixed with other substances unless specifically instructed by a healthcare professional.